U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 55 results

Status:
US Approved Rx (2021)
First approved in 2021

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Difelikefalin (Korsuva™) is a synthetic peptide agonist of the kappa opioid receptor being developed by Cara Therapeutics for the treatment of pruritus. In August 2021, intravenous difelikefalin was approved in the USA for the treatment of moderate-t...
Status:
US Approved Rx (2017)
First approved in 2013

Class (Stereo):
CHEMICAL (ACHIRAL)



Umeclidinium (used as a bromide salt) is a long-acting, antimuscarinic antagonist, often referred to as an anticholinergic, developed for the treatment of chronic obstructive pulmonary disease (COPD) (alone and in combination with Vilanterol - long-a...
Status:
US Approved Rx (2016)
First approved in 2011

Class (Stereo):
CHEMICAL (ABSOLUTE)



Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor discovered by Boehringer Ingelheim and being developed as an oral once-daily tablet for the treatment of Type 2 diabetes. Linagliptin was first approved by FDA in 2011 under the trade name Tra...
Status:
US Approved Rx (2025)
First approved in 2005

Class (Stereo):
CHEMICAL (RACEMIC)



Lenalidomide (trade name Revlimid) is a derivative of thalidomide introduced in 2004. It is an immunomodulatory agent with anti-angiogenic properties. Revlimid in combination with dexamethasone is indicated for the treatment of patients with multipl...
Status:
US Approved Rx (2010)
First approved in 2004

Class (Stereo):
CHEMICAL (ABSOLUTE)



Pregabalin, marketed under the brand name Lyrica among others. LYRICA is indicated for: Neuropathic pain associated with diabetic peripheral neuropathy (DPN) Postherpetic neuralgia (PHN); Adjunctive therapy for adult patients with partial onset seizu...
Status:
US Approved Rx (2016)
First approved in 1995

Class (Stereo):
CHEMICAL (ACHIRAL)



Metformin is the most widely used drug to treat type 2 diabetes, and is one of only two oral antidiabetic drugs on the World Health Organization (WHO) list of essential medicines. Metformin is an antihyperglycemic agent which improves glucose tolera...
Status:
US Approved Rx (2002)
First approved in 1989

Class (Stereo):
CHEMICAL (ACHIRAL)



Clozapine was discovered in 1958 by an anesthetist and now it is used for the treatment of schizophrenia. Although the exact mechanism of its action is unknown, the effect of clozapine on schizophrenia is associated with inhibition of dopamine D2 and...
Status:
US Approved Rx (2001)
First approved in 1986

Class (Stereo):
CHEMICAL (RACEMIC)



Ipratropium (ipratropium bromide, ATROVENT® HFA) is a muscarinic antagonist structurally related to atropine but often considered safer and more effective for inhalation use. It is indicated for the maintenance treatment of bronchospasm associated wi...
Status:
US Approved Rx (1967)
First approved in 1967

Class (Stereo):
CHEMICAL (ACHIRAL)



Hydroxyurea is an oral antimetabolite; inhibits ribonucleotide reductase and DNA synthesis. It is used for resistant chronic myeloid leukemia, locally advanced squamous cell carcinomas of the head and neck (excluding lip) in combination with concurre...
Status:
US Approved Rx (1999)
First approved in 1967

Class (Stereo):
CHEMICAL (ABSOLUTE)



ETHAMBUTOL HYDROCHLORIDE is an oral chemotherapeutic agent which is specifically effective against actively growing microorganisms of the genus Mycobacterium, including M. tuberculosis. Ethambutol inhibits RNA synthesis and decreases tubercle bacilli...